Key facts
- This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 24 Jun 2022, 16:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Award
No transaction description listed
No transaction description listed
Award
| Id | Content |
|---|---|
| F1 | Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer. |
| F2 | The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill. |
| F3 | The option vests in twelve equal monthly installments beginning on July 13, 2022. |
Exhibit List - Exhibit 24 - Power of Attorney